Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
Author:
Publisher
Humana Press
Link
http://link.springer.com/content/pdf/10.1007/978-1-60761-803-4_8
Reference22 articles.
1. Cannon, C.P., Husted, S., Harrington, R.A., et al. (2007) Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial J Am Coll Cardiol 50, 1844–51.
2. Greenbaum, A.B., Grines, C.L., Bittl, J.A., et al. (2006) Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial Am Heart J 151, 689.
3. Becker, R.C., Moliterno, D.J., Jennings, L.K., Pieper, K.S., Pei, J., Niederman, A., Ziada, K.M., Berman, G., Strony, J., Joseph, D., Mahaffey, K.W., Van de Werf, F., Veltri, E., and Harrington, R.A, and for the TRA-PCI Investigators. (2009) Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomized, double-blind, placebo-controlled phase II study Lancet 373, 919–28.
4. Nguyen, T.A., Diodati, J.G. and Pharand, C. (2005) Resistance to clopidogrel: a review of the evidence JACC 45, 1157–64.
5. Jakubowski, J.A., Payne, C.D., Li, Y.G., et al. (2008) A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry Thromb Haemost 99, 215–22.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Optimal Antiplatelet Therapy in ST-Segment Elevation Myocardial Infarction;Interventional Cardiology Clinics;2016-10
2. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors;European Journal of Medicinal Chemistry;2016-01
3. DEVELOPMENT AND VALIDATION OF STABILITY INDICATING REVERSE-PHASE HPLC METHOD FOR THE DETERMINATION OF PRASUGREL HYDROCHLORIDE AND ITS RELATED SUBSTANCES;International journal of pharmaceutical sciences and research;2014-03-01
4. Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?;Thrombosis;2012-11-09
5. Effects of P2Y1 receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel;British Journal of Pharmacology;2012-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3